Devotion, it seems, is finding a new address. It may be a café, a college courtyard, a rooftop, or an open air venue glowing with soft lights and incense. The sound is familiar yet unexpected. Ancient ...

An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer’s disease. The corresponding study was published in Alzheimer’s & Dementia. "Alzheimer's disease begins ...

Masimo (MASI) has been under steady pressure in recent sessions, with the stock slipping again at the latest close as investors reassess its slower revenue trajectory against improving profitability.

Shares of digital banking platform Nubank (NYSE:NU) jumped 1.9% in the morning session after it received positive analyst commentary and the launch of a new investment product. Goldman Sachs ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer's disease. In a new study, Northwestern scientists identified a ...

Four years on from the conclusion of his F1 tenure as Race Director, Michael Masi has taken on a new role in New Zealand. Masi took over from the late Charlie Whiting as the FIA’s Race Director and ...

Nu Holdings demonstrates strong growth momentum, adding over 17M new customers in Q3. Revenues soared 42% year-over-year. The Fintech has a superior growth profile and a low valuation relative to ...

NU’s Q3 showed scale turning into a structural advantage, with 127M customers, rising ARPAC and industry-leading efficiency that allows the company to grow without adding operational friction. Revenue ...

Nu shares generated a trailing three-year return that trounces the broader market. Rapid customer growth helped propel revenue and profits to new heights. 10 stocks we like better than Nu Holdings › ...

We’re about a quarter-century removed from the days when nu metal ruled the airwaves, and the once-maligned subgenre of music continues to hold a hell of a lot more cultural significance than its ...